Apr.30
11:14 AM ET
Monday, 30 Apr 2012
Posted By:ReutersCNBC Stock Blog Europe
AstraZeneca may be lacking both drugs and a CEO, but for brave investors this might be the time to buy the stock. Read More
Apr.16
11:34 AM ET
Monday, 16 Apr 2012
Posted By:Nathan Sadeghi-NejadCNBC Stock Blog
Why Amylin Pharmaceuticals shareholders should demand transparency and a public explanation of recent takeover talk. Read More
Topics:Investment Strategy | NYSE | Stock Market | Stock Options | Stock Picks
Companies:S | Eli Lilly and Company | Bristol-Myers Squibb Co | Amylin Pharmaceuticals
Apr.03
6:20 PM ET
Tuesday, 3 Apr 2012
That’s just one of several headlines that came out of Fast Money's exclusive interview with billionaire investor Carl Icahn. Read More
Topics:Stock Market | Stock Picks
Companies:Research in Motion Limited | Amylin Pharmaceuticals
Mar.12
3:00 PM ET
Monday, 12 Mar 2012
Posted By:Adam FeuersteinCNBC Stock Blog
After a hot streak, biotech stocks lose value as clinical trials fail. Read More
Topics:Earnings | Investment Strategy | Nasdaq Composite | NYSE | Stock Market | Stock Options | Stock Picks
Feb.02
12:13 PM ET
Thursday, 2 Feb 2012
Shares of the following companies are showing unusual moves in Thursday's trading session. Read More
Jan.09
6:12 PM ET
Monday, 9 Jan 2012
Alkermes expects FDA approval for its new diabetes drug this month, but that might not be enough to make the stock worth buying, trader Guy Adami said. Read More
Topics:Stock Market | Stock Picks
Companies:Alkermes Inc | Eli Lilly and Company | Amylin Pharmaceuticals
Nov.14
7:07 PM ET
Monday, 14 Nov 2011
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now! Read More
Topics:Stock Market | Stock Picks
Companies:Home Depot Inc | Amylin Pharmaceuticals | Carnival Plc ADS | Yahoo! Inc
VIDEO | COMPANIES : Amylin Pharmaceuticals
Ahead of the Facebook IPO, the company wants to make privacy policies clear and simple, reports CNBC's Julia Boorstin. S...
Cramer shares six stocks to watch, and reveals them in under 60 seconds.
CNBC's Seema Mody reports on the latest details of the FDA advisory panel's review of Arena Pharmaceuticals' anti-obesit...
The FMHR traders share their top trades of the hour. Jonathan Chaplin, Credit Suisse analyst, explains why his firm upgr...
CNBC's Brian Shactman reports JP Morgan shares are down almost 7% in after-hours trading; Yahoo's CEO says he didn't pro...
More VideosNews |
COMPANY : Amylin Pharmaceuticals
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
